Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets

v3.23.2
Condensed Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Current Assets:    
Cash and cash equivalents $ 7,421 $ 12,068
Prepaid expenses and other current assets 886 1,149
Other receivables - related party 31 73
Total current assets 8,338 13,290
Total Assets 8,338 13,290
Current Liabilities:    
Accounts payable and accrued expenses 25,194 20,297
Accounts payable and accrued expenses - related party 2,453 1,306
Common stock warrant liabilities 3,961 11,170
Total current liabilities 31,608 32,773
Total Liabilities 31,608 32,773
Commitments and Contingencies
Stockholders' (Deficit) Equity    
Common stock issuable, 0 and 368,907 shares as of June 30, 2023 and December 31, 2022, respectively   1,885
Additional paid-in capital 266,209 241,117
Accumulated deficit (289,481) (262,486)
Total Stockholders' (Deficit) Equity (23,270) (19,483)
Total Liabilities and Stockholders' (Deficit) Equity 8,338 13,290
Common No Class    
Stockholders' (Deficit) Equity    
Common Stock Value $ 2 $ 1